Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

GE HealthCare Technologies (GEHC) Research & Development (2022 - 2025)

Historic Research & Development for GE HealthCare Technologies (GEHC) over the last 4 years, with Q4 2025 value amounting to $323.0 million.

  • GE HealthCare Technologies' Research & Development fell 610.47% to $323.0 million in Q4 2025 from the same period last year, while for Dec 2025 it was $1.3 billion, marking a year-over-year decrease of 381.39%. This contributed to the annual value of $1.3 billion for FY2025, which is 389.02% down from last year.
  • As of Q4 2025, GE HealthCare Technologies' Research & Development stood at $323.0 million, which was down 610.47% from $292.0 million recorded in Q3 2025.
  • Over the past 5 years, GE HealthCare Technologies' Research & Development peaked at $344.0 million during Q4 2024, and registered a low of $238.0 million during Q1 2022.
  • Its 4-year average for Research & Development is $300.2 million, with a median of $308.5 million in 2023.
  • Per our database at Business Quant, GE HealthCare Technologies' Research & Development surged by 2384.62% in 2023 and then crashed by 764.53% in 2025.
  • Over the past 4 years, GE HealthCare Technologies' Research & Development (Quarter) stood at $271.0 million in 2022, then increased by 16.24% to $315.0 million in 2023, then rose by 9.21% to $344.0 million in 2024, then dropped by 6.1% to $323.0 million in 2025.
  • Its Research & Development stands at $323.0 million for Q4 2025, versus $292.0 million for Q3 2025 and $302.0 million for Q2 2025.